Human retinal pigment epithelium cell changes and expression of αB-crystallin: A biomarker for retinal pigment epithelium cell change in age-related macular degeneration

Soma De, David M. Rabin, Enrique Salero, Patricia L. Lederman, Sally Temple, Jeffrey H. Stern

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Objective: To examine changes in the retinal pigment epithelium (RPE) in eyes with age-related macular degeneration (AMD) and specifically to characterize αB-crystallin expression in RPE cells as a biomarker in this disease. Methods: Maculae from human patients diagnosed as having AMD or from age-matched control eyes were isolated, cryosectioned, and analyzed immunohistochemically for αB-crystallin and for cell type-specific markers. Results: In eyes with dry and wet AMD, αB-crystallin was heterogeneously expressed by a subpopulation of RPE cells in the macular region (frequently in cells adjacent to drusen) and in areas of RPE hypertrophy associated with wet AMD. In contrast, αB-crystallin was not detected at significant levels in control RPE. Conclusion: Accompanying the formation of drusen in early-stage and late-stage AMD, RPE cells undergo change to express αB-crystallin. Clinical Relevance: The detection of αB-crystallin in the RPE of patients with early and advanced AMD implicates this as an AMD biomarker. Sporadic expression of αB-crystallin by RPE cells localized adjacent to drusen in early AMD indicates that changes in the gene expression of RPE cells accompany early stages of the disease and introduces novel potential targets for AMD therapy.

Original languageEnglish
Pages (from-to)641-646
Number of pages6
JournalArchives of Ophthalmology
Volume125
Issue number5
DOIs
StatePublished - May 1 2007

Fingerprint

Crystallins
Retinal Pigment Epithelium
Macular Degeneration
Biomarkers
Pigment Epithelium of Eye
Hypertrophy
Gene Expression

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Human retinal pigment epithelium cell changes and expression of αB-crystallin : A biomarker for retinal pigment epithelium cell change in age-related macular degeneration. / De, Soma; Rabin, David M.; Salero, Enrique; Lederman, Patricia L.; Temple, Sally; Stern, Jeffrey H.

In: Archives of Ophthalmology, Vol. 125, No. 5, 01.05.2007, p. 641-646.

Research output: Contribution to journalArticle

De, Soma ; Rabin, David M. ; Salero, Enrique ; Lederman, Patricia L. ; Temple, Sally ; Stern, Jeffrey H. / Human retinal pigment epithelium cell changes and expression of αB-crystallin : A biomarker for retinal pigment epithelium cell change in age-related macular degeneration. In: Archives of Ophthalmology. 2007 ; Vol. 125, No. 5. pp. 641-646.
@article{78719737459b4982bdf703d7e7134795,
title = "Human retinal pigment epithelium cell changes and expression of αB-crystallin: A biomarker for retinal pigment epithelium cell change in age-related macular degeneration",
abstract = "Objective: To examine changes in the retinal pigment epithelium (RPE) in eyes with age-related macular degeneration (AMD) and specifically to characterize αB-crystallin expression in RPE cells as a biomarker in this disease. Methods: Maculae from human patients diagnosed as having AMD or from age-matched control eyes were isolated, cryosectioned, and analyzed immunohistochemically for αB-crystallin and for cell type-specific markers. Results: In eyes with dry and wet AMD, αB-crystallin was heterogeneously expressed by a subpopulation of RPE cells in the macular region (frequently in cells adjacent to drusen) and in areas of RPE hypertrophy associated with wet AMD. In contrast, αB-crystallin was not detected at significant levels in control RPE. Conclusion: Accompanying the formation of drusen in early-stage and late-stage AMD, RPE cells undergo change to express αB-crystallin. Clinical Relevance: The detection of αB-crystallin in the RPE of patients with early and advanced AMD implicates this as an AMD biomarker. Sporadic expression of αB-crystallin by RPE cells localized adjacent to drusen in early AMD indicates that changes in the gene expression of RPE cells accompany early stages of the disease and introduces novel potential targets for AMD therapy.",
author = "Soma De and Rabin, {David M.} and Enrique Salero and Lederman, {Patricia L.} and Sally Temple and Stern, {Jeffrey H.}",
year = "2007",
month = "5",
day = "1",
doi = "10.1001/archopht.125.5.641",
language = "English",
volume = "125",
pages = "641--646",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Human retinal pigment epithelium cell changes and expression of αB-crystallin

T2 - A biomarker for retinal pigment epithelium cell change in age-related macular degeneration

AU - De, Soma

AU - Rabin, David M.

AU - Salero, Enrique

AU - Lederman, Patricia L.

AU - Temple, Sally

AU - Stern, Jeffrey H.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - Objective: To examine changes in the retinal pigment epithelium (RPE) in eyes with age-related macular degeneration (AMD) and specifically to characterize αB-crystallin expression in RPE cells as a biomarker in this disease. Methods: Maculae from human patients diagnosed as having AMD or from age-matched control eyes were isolated, cryosectioned, and analyzed immunohistochemically for αB-crystallin and for cell type-specific markers. Results: In eyes with dry and wet AMD, αB-crystallin was heterogeneously expressed by a subpopulation of RPE cells in the macular region (frequently in cells adjacent to drusen) and in areas of RPE hypertrophy associated with wet AMD. In contrast, αB-crystallin was not detected at significant levels in control RPE. Conclusion: Accompanying the formation of drusen in early-stage and late-stage AMD, RPE cells undergo change to express αB-crystallin. Clinical Relevance: The detection of αB-crystallin in the RPE of patients with early and advanced AMD implicates this as an AMD biomarker. Sporadic expression of αB-crystallin by RPE cells localized adjacent to drusen in early AMD indicates that changes in the gene expression of RPE cells accompany early stages of the disease and introduces novel potential targets for AMD therapy.

AB - Objective: To examine changes in the retinal pigment epithelium (RPE) in eyes with age-related macular degeneration (AMD) and specifically to characterize αB-crystallin expression in RPE cells as a biomarker in this disease. Methods: Maculae from human patients diagnosed as having AMD or from age-matched control eyes were isolated, cryosectioned, and analyzed immunohistochemically for αB-crystallin and for cell type-specific markers. Results: In eyes with dry and wet AMD, αB-crystallin was heterogeneously expressed by a subpopulation of RPE cells in the macular region (frequently in cells adjacent to drusen) and in areas of RPE hypertrophy associated with wet AMD. In contrast, αB-crystallin was not detected at significant levels in control RPE. Conclusion: Accompanying the formation of drusen in early-stage and late-stage AMD, RPE cells undergo change to express αB-crystallin. Clinical Relevance: The detection of αB-crystallin in the RPE of patients with early and advanced AMD implicates this as an AMD biomarker. Sporadic expression of αB-crystallin by RPE cells localized adjacent to drusen in early AMD indicates that changes in the gene expression of RPE cells accompany early stages of the disease and introduces novel potential targets for AMD therapy.

UR - http://www.scopus.com/inward/record.url?scp=34248553886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248553886&partnerID=8YFLogxK

U2 - 10.1001/archopht.125.5.641

DO - 10.1001/archopht.125.5.641

M3 - Article

C2 - 17502503

AN - SCOPUS:34248553886

VL - 125

SP - 641

EP - 646

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 5

ER -